US Patent Issued to The University of Chicago on Aug. 18 for "Compositions and methods concerning combinations of immunologic inhibitors for the treatment of cancer" (Illinois Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,667, issued on Aug. 18, was assigned to The University of Chicago (Chicago).

"Compositions and methods concerning combinations of immunologic inhibitors for the treatment of cancer" was invented by Thomas F. Gajewski (Chicago), Stefani Spranger (Chicago) and Michael Leung (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects herein relate to combinations of inhibitors useful in the treatment of cancer, and methods of treating cancer using such combinations. In some embodiments, the methods involve the use of a combination of at least two of the following: an inhibitor of indoleamine-2,3-dioxygenase (IDO), an inhibitor of the PD-L1/PD-1 pat...